FGP
LLY icon

Freestone Grove Partners’s Eli Lilly LLY Stock Holding History

Freestone Grove Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Buy
+13,442
New +$13.7M 0.1% 231
2026
Q1 		– Sell
-53,593
Closed -$57.6M – 1097
2025
Q4 		$57.6M Buy
53,593
+34,078
+175% +$32.6M 0.42% 62
2025
Q3 		$14.9M Sell
19,515
-9,113
-32% -$6.78M 0.11% 250
2025
Q2 		$22.3M Buy
+28,628
New +$22.2M 0.17% 187
2025
Q1 		– Sell
-1,469
Closed -$1.13M – 702
2024
Q4 		$1.13M Buy
+1,469
New +$1.22M 0.01% 295

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Freestone Grove Partners's LLY Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 13,442 shares worth $16.1M. The stake represents 0.1% of the portfolio and ranks #231 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in LLY as recently as Q4 2025.

Freestone Grove Partners first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. The position peaked at $57.6M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Freestone Grove Partners held 13,442 shares of Eli Lilly worth $16.1M as of Q2 2026.
  • Eli Lilly was a new Freestone Grove Partners position in Q2 2026.
  • Eli Lilly made up 0.1% of Freestone Grove Partners's portfolio in Q2 2026, its #231 holding.
  • Freestone Grove Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
  • Freestone Grove Partners's Eli Lilly position peaked at $57.6M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.